June is Alzheimer's Awareness Month. And today, we bring you one man's story of hope. After participating in clinical trials for a new Alzheimer's drug, which recently received FDA approval, he feels he's benefited from the therapy. Erica Foreman has more. The new drug is the first shown to slow progression of Alzheimer's Disease. It should be available to patients in the the coming weeks. However, it's expected to be expensive, and, for the time being, won't be covered by insurance.